Press Release

februari 15, 2018

DSM to exclusively market BIOMILK 300 residual lactose analyzer, expanding availability for dairy producers worldwide

BIOMILK 300 is a compact residual lactose-analyzing device offering dairy producers a fast, cost-effective, and accurate analyzer for quantifying residual lactose levels in lactose-free and lactose-reduced dairy products

Afdrukken

Delft, NL, 15 Feb 2018 10:00 CET

DSM, a global science-based company active in health, nutrition and materials, announces today that it will exclusively market BIOMILK 300, a compact residual lactose-analyzing device produced by BIOLAN, as from February 2018. For dairy producers, the BIOMILK 300 is a fast, cost-effective, and accurate analyzer for quantifying residual lactose levels in lactose-free and lactose-reduced dairy products.

×

Consumers are increasingly aware of the health appeal of lactose-free dairy, which is driving rapid growth for this segment. To keep pace with this growth, it is crucial for lactose-free dairy producers to have an accurate and fast measurement of the residual lactose-level at every moment in their process, resulting in shorter lead times.

DSM, the world-leading lactase specialist, recognized the need among its customers for fast, reliable measurement of residual lactose levels that is also cost-effective. As a result, DSM has partnered with BIOLAN, an innovative company which designs and manufactures analytical solutions based on biosensor technology, to bring BIOMILK 300 to a larger proportion of the global dairy industry.

DSM is very pleased to partner with BIOLAN to bring this remarkable technology to a wider use within the dairy industry,” says Merel Roes, Global Business Line Manager Dairy Enzymes at DSM. “BIOLAN’s expertise with biosensor technology, together with DSM’s strong history as a leading lactase producer and partner in the dairy industry, allows us to meet the growing needs of manufacturers of lactose-free dairy products even better than before.

The BIOMILK 300 offers several benefits, including having a fast analysis time of less than 3 minutes, being cost-effective and accurate with a high sensitivity that can detect and quantify residual lactose levels at less than 0.01%. It is also easy to use, requiring no extensive lab skills to operate or any additional equipment to read the results.

The BIOMILK 300 is recommended for use with Maxilact®, DSM’s market-leading lactase range. With Maxilact, dairy producers can produce lactose-free dairy products that taste great while achieving lactose levels in products that are lower than 0.01%—the future standard in the industry.

For more information
Stephen Hufton

Senior Communications Manager
Nutrition
+31 6 1300 1159

Disclaimer met betrekking tot vertalingen Deze pagina is automatisch vertaald met behulp van AI. Hoewel we streven naar nauwkeurigheid, kunnen vertalingen onvolledig zijn of de oorspronkelijke inhoud verkeerd weergeven. Raadpleeg voor belangrijke informatie de versie in de oorspronkelijke taal. Gebruik AI-vertalingen op eigen verantwoordelijkheid. DSM-Firmenich is niet aansprakelijk voor eventuele fouten of misverstanden die voortvloeien uit deze vertalingen.